| Katrina Almeida, DPM | |
|
1415 Woodland Ave, Suite 140, Des Moines, IA 50309-3203 | |
| (515) 241-4076 | |
| Not Available |
| Full Name | Katrina Almeida |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 9 Years |
| Location | 1415 Woodland Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063895860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 078070 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Gregory Hospital | Gregory, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Queen Of Peace | 9335050806 | 84 |
News Archive
Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
Circadian Technologies Limited today released data at the American Association for Cancer Research (AACR) annual conference in Orlando, Florida (U.S.A.) demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer.
› Verified 1 days ago
| Provider Name | Avera Queen Of Peace |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
Circadian Technologies Limited today released data at the American Association for Cancer Research (AACR) annual conference in Orlando, Florida (U.S.A.) demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer.
› Verified 1 days ago
| Provider Name | Avera Queen Of Peace |
|---|---|
| Provider Type | Part A Provider - Critical Access Hospital |
| Provider Identifiers | NPI Number: 1992466635 PECOS PAC ID: 9335050806 Enrollment ID: O20220301001771 |
News Archive
Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
Circadian Technologies Limited today released data at the American Association for Cancer Research (AACR) annual conference in Orlando, Florida (U.S.A.) demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katrina Almeida, DPM 1415 Woodland Ave, Suite 140, Des Moines, IA 50309-3203 Ph: (515) 241-4076 | Katrina Almeida, DPM 1415 Woodland Ave, Suite 140, Des Moines, IA 50309-3203 Ph: (515) 241-4076 |
News Archive
Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of Generex common stock.
Circadian Technologies Limited today released data at the American Association for Cancer Research (AACR) annual conference in Orlando, Florida (U.S.A.) demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer.
› Verified 1 days ago
Dr. Jarrod Alexander Smith, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Grand Ave, Des Moines, IA 50312 Phone: 515-271-1731 | |
Dr. David Albert Yount, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2459 E Euclid Ave, Suite A, Des Moines, IA 50317 Phone: 515-262-5856 Fax: 515-262-6446 | |
Ronald P Belin, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-2200 | |
James Michael Mahoney, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Grand Ave, Des Moines, IA 50312 Phone: 515-271-1731 Fax: 515-271-1692 | |
John David Bennett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Grand Ave, Des Moines, IA 50312 Phone: 515-271-1731 Fax: 515-271-1692 | |
Sean T Grambart, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Grand Ave, Des Moines, IA 50312 Phone: 515-271-1700 |